Business · 08/12/2023Updated: 10/17/2026 · 1 min read
Bayer HealthCare Pharmaceuticals Inc. Withdraws FDA Approval of Ciprofloxacin Hydrochloride Oral Tablets
Summary
The FDA is withdrawing approval of Ciprofloxacin Hydrochloride oral tablets, equivalent to 100mg base, and generic versions, following a request from the product holders to withdraw the 100mg strength products and waive a hearing.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →